Basic Calan Information

• INN (International Nonproprietary Name): Verapamil.
• Brand Names Available In Canada (English): Isoptin SR and generic verapamil products; Calan noted as US (discontinued) and generic verapamil available worldwide.
• ATC Code: C08DA01.
• Forms & Dosages: Tablets 40 mg, 80 mg, 120 mg; Extended‑release tablets 120 mg, 180 mg, 240 mg; Extended‑release capsules 100 mg, 120 mg, 180 mg, 240 mg; Intravenous solution 2.5 mg/mL (5 mg/2 mL ampoules) — IV form noted in some markets.
• Manufacturers In Canada (English): Global manufacturers listed include Abbott, Pfizer, Mylan, Teva, Sandoz; local suppliers vary and may be not specified on each package.
• Registration Status In Canada (English): Prescription‑only in most regions with Isoptin SR available in Canada and generic verapamil marketed under various product names.
• OTC / Rx Classification: Prescription only (Rx only) in most jurisdictions.

Important Patient Notes, Warnings And Daily-Life Tips

Read the patient leaflet and check the Drug Identification Number (DIN) on the package before taking any verapamil product.

Only take verapamil if it has been prescribed to you by a clinician who knows your medical history.

Keep an up-to-date medicines list and bring it to every healthcare visit.

If you live rurally or cross the Canada–US border for drugs, confirm prescriptions meet Health Canada and DIN requirements before travel.

Warning: stop the medicine and seek urgent care for severe dizziness, fainting, very slow pulse, severe swelling, or chest pain.

Do not mix verapamil with grapefruit juice because of a marked CYP3A4 interaction risk.

Discuss alcohol use with your clinician because alcohol can worsen dizziness or low blood pressure when combined with verapamil.

Daily-life integration tips: set a phone alarm for doses and carry a small printed list of contraindications such as pacemaker status and AV block.

Use blister packs or pharmacy blistering services offered by chains such as Shoppers Drug Mart, Rexall, or London Drugs to avoid missed doses.

For cost help, check provincial plans (such as ODB, PharmaCare, RAMQ) for coverage or ask your pharmacist about generic verapamil options.

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Which routine fits you best depends on the formulation prescribed and your daily schedule.

Immediate‑release verapamil is taken multiple times per day and often requires a morning, mid‑day, and evening schedule to maintain even blood levels.

Extended‑release or sustained‑release products typically allow once‑ or twice‑daily dosing and are easier to fit into a busy workday.

For many Canadians who work daytime hours, taking verapamil ER with breakfast reduces the chance of a missed dose.

Some extended‑release products are evening‑timed in other markets, so confirm timing with your prescriber before switching formulations.

Tip: if you commute long hours or have variable shifts, talk to your pharmacist about switching to an ER product for once‑daily adherence.

• Example IR schedule: 80 mg in the morning, 80 mg mid‑day, 80 mg in the evening as prescribed.
• Example ER schedule: 180–240 mg once daily with breakfast for steady control of blood pressure and angina.
• When switching from IR to ER, allow your prescriber to adjust the dose and monitor for side effects.

Taking With Or Without Meals (Canadian Diet Context)

Verapamil may be taken with or without food according to product labelling and prescriber advice.

High‑fat meals can alter absorption of some formulations, so keep timing consistent relative to meals to stabilise blood levels.

In Canada’s varied diets, try to take the ER tablet at the same meal each day — commonly with breakfast for daytime workers.

If you notice differences in how you feel when taking verapamil with a heavy versus light meal, report this to your pharmacist.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Do not take verapamil if you have severe hypotension, defined as systolic blood pressure under 90 mmHg.

A history of sick sinus syndrome or second‑ or third‑degree AV block without a pacemaker is an absolute contraindication.

Avoid verapamil in severe left ventricular dysfunction or cardiogenic shock.

Stop and seek urgent care for hypersensitivity reactions to verapamil or excipients.

Patients with bradycardia (resting heart rate under 50 bpm) require close assessment before starting verapamil.

Combination with other negative inotropes such as beta‑blockers increases the risk of symptomatic bradycardia and should be managed by a clinician.

Activities To Limit (Driving, Workplace Safety)

Do not drive, operate heavy machinery, or perform tasks requiring full alertness if you experience dizziness, syncope, or marked slowing of the heart rate on verapamil.

If you work in remote driving, shift work, or safety‑sensitive roles, discuss workplace safety and monitoring with your clinician.

For rural patients, ensure emergency contacts and local clinic details are saved in your phone and written on a wallet card.

• Checklist: confirm pacemaker status on your chart before starting verapamil.
• Checklist: baseline blood pressure and resting heart rate recorded and shared with your prescriber.
• Checklist: suspend driving and heavy equipment operation if new dizziness, fainting, or profound fatigue appear.

Dosage & Adjustments

General Regimen (DIN References)

Typical adult dosing for immediate‑release verapamil is 80–120 mg taken orally three times daily as indicated by the product label.

Extended‑release or sustained‑release formulations are usually 180–240 mg once or twice daily depending on the specific product and prescriber instructions.

Intravenous verapamil is used only in hospital settings for acute arrhythmias and is dosed at 5–10 mg IV with the possibility of a repeat after 30 minutes under monitoring.

In Canada, prescriptions should show the DIN and product name so you can confirm formulation and strength at the pharmacy.

Special Cases (Elderly, Comorbidities)

Start at lower doses and titrate slowly for older adults due to increased sensitivity and the risk of renal or hepatic impairment.

Liver disease and significant renal impairment typically call for dose reductions and closer monitoring for signs of toxicity.

When patients are on interacting drugs such as statins, digoxin, or strong CYP3A4 inhibitors, expect dose changes or alternative therapy to be considered.

Children require specialist dosing and should use verapamil only under pediatric cardiology guidance.

User Testimonials

Positive Reports From Canadian Patients

Many patients report improved blood pressure control and fewer angina episodes after switching to an extended‑release verapamil product such as Isoptin SR or a generic ER formulation.

Patients who previously took multiple daily immediate‑release doses commonly report better adherence after changing to once‑daily ER tablets.

Commuters and shift workers often mention that pharmacy refill services at Shoppers Drug Mart or mail order delivery improved continuity of therapy.

Common Challenges In Forums (Reddit Canada, Health Boards)

Common side effects reported on Canadian forums include constipation, ankle swelling, and dizziness when starting therapy.

Many forum threads recommend keeping a symptom diary for the first two to four weeks and reporting persistent constipation to a pharmacist for non‑prescription remedies like fibre or stool softeners.

Rural patients frequently mention delays in refills and limited local cardiology access, and some recommend mail‑order pharmacy services or provincial pharmacist prescribing where available.

• Pro: Improved angina control on ER formulations such as Isoptin SR.
• Con: Constipation and peripheral edema are commonly reported and manageable with counselling.
• Forum tip: always check for interactions posted in patient threads, particularly with statins, digoxin, and beta‑blockers.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Verapamil is prescription‑only and available as generic verapamil and as branded Isoptin SR in Canada.

Major pharmacy chains such as Shoppers Drug Mart, Rexall, London Drugs, and Jean Coutu in Quebec can stock or order verapamil products and will confirm the DIN at dispensing.

Independent pharmacies may also be able to source products and advise about provincial coverage and substitution options.

Price Comparison (In-Store Vs Online, Cross‑Border Notes)

Generic extended‑release verapamil is typically less expensive than branded Isoptin SR, though prices vary by pharmacy and provincial coverage.

Online pharmacy prices may appear lower, but confirm the pharmacy is licensed in Canada and that the product carries a Canadian DIN.

Calan is discontinued in the US market, and other brands such as Calan SR, Verelan, or Verelan PM exist in different countries.

If you consider bringing a US product into Canada while travelling, check Health Canada guidance and confirm import compliance with your pharmacist beforehand.

What’s Inside & How It Works

Ingredients Overview

The active ingredient is verapamil hydrochloride.

Excipients vary by manufacturer and are shown on package labelling — check labels if you have allergies.

Available formulations include 40 mg, 80 mg, and 120 mg tablets and extended‑release tablets and capsules of 100–240 mg strengths.

Intravenous solution is available in some markets as 2.5 mg/mL in 5 mg/2 mL ampoules.

Mechanism Basics

Verapamil is a phenylalkylamine calcium‑channel blocker with ATC code C08DA01.

It reduces calcium influx into cardiac and vascular smooth muscle cells, lowering heart rate, slowing AV nodal conduction, and reducing myocardial oxygen demand.

These pharmacologic effects explain verapamil’s roles in treating hypertension, angina, and certain supraventricular arrhythmias.

Because verapamil slows AV conduction, patients with conduction disease need ECG monitoring and careful dose selection.

• Formulation note: ER/SR products are designed for steadier plasma levels and improved adherence.
• Mechanism highlight: stronger AV‑nodal suppression compared with dihydropyridine CCBs.

Main Indications

Approved Uses In Canada

Verapamil is prescribed for hypertension, angina pectoris including variant angina, and certain arrhythmias such as atrial fibrillation/flutter and paroxysmal supraventricular tachycardia.

Health Canada and provincial formularies guide specific product choices and funding for these indications.

Off‑Label Uses By Canadian Physicians

Off‑label uses occasionally include migraine prophylaxis or cluster headache in specialist contexts, though such uses require specialist oversight.

Verapamil may be chosen for rate control in atrial fibrillation when beta‑blockers are unsuitable, under specialist guidance.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Avoid regular grapefruit juice because it markedly increases verapamil levels via CYP3A4 inhibition.

Alcohol can worsen dizziness or hypotension when combined with verapamil, so discuss your alcohol intake with your clinician.

Caffeine does not have a major interaction with verapamil but can affect blood pressure and should be discussed if you notice changes.

Drug Conflicts (Health Canada Database)

Verapamil inhibits CYP3A4 and can increase statin levels, particularly simvastatin, which raises myopathy risk.

Verapamil can raise digoxin levels and necessitates digoxin monitoring and possible dose adjustment.

Combined use with beta‑blockers or other negative inotropes increases the risk of bradycardia, AV block, and heart failure.

Use the Health Canada Drug Product Database or bring a full medication list to your pharmacist for a comprehensive interaction screen.

• Immediate action checklist: stop any suspect OTC herbal product and call your pharmacist if you suspect an interaction.
• Seek urgent care for syncope, severe dizziness, or signs of symptomatic bradycardia.
• Always bring a complete list of prescription, OTC, and herbal medicines to the pharmacy.

Latest Evidence & Insights

Verapamil’s role in hypertension, angina, and supraventricular tachycardia is well established in international guidelines and clinical trials.

Comparative trials and meta‑analyses show different side‑effect profiles across calcium channel blocker subclasses, with dihydropyridines such as amlodipine causing more peripheral oedema and reflex tachycardia.

Verapamil offers stronger AV‑nodal suppression, making it useful for arrhythmia rate control where that property is desired.

Canadian studies and regulatory notes emphasise careful patient selection because of verapamil’s negative inotropic effects, particularly in patients with heart failure.

Clinicians and informed patients should consult provincial formularies and Health Canada product notices for up‑to‑date information on availability and safety signals.

Alternative Choices

Amlodipine is a commonly used dihydropyridine calcium channel blocker with once‑daily dosing and potent vasodilation for hypertension.

Diltiazem shares AV nodal effects with verapamil but has a slightly different side‑effect profile and can be an alternative for rate control.

Nifedipine and other dihydropyridines act mainly on vascular smooth muscle and are not preferred for AV‑nodal suppression.

• Amlodipine — Primary use: hypertension; Pros: once‑daily dosing and potent BP lowering; Cons: peripheral oedema, reflex tachycardia.
• Diltiazem — Primary use: hypertension, angina, arrhythmia rate control; Pros: intermediate AV nodal effect; Cons: bradycardia risk similar to verapamil.
• Nifedipine — Primary use: hypertension and acute BP control; Pros: strong vasodilation; Cons: not useful for AV‑nodal suppression.

Switching agents should be done under clinician supervision to avoid rebound hypertension or worsening angina, and provincial drug‑plan coverage should be checked when considering alternatives.

Regulation Snapshot

Verapamil is prescription‑only in most jurisdictions and requires a valid DIN on marketed packages in Canada.

Isoptin SR is available in Canada while some US brands such as Calan have different availability or are discontinued in certain markets.

Prescribers and pharmacists should ensure the DIN matches the prescribed formulation (IR vs ER) and document counselling at dispensing.

Patients who travel or consider cross‑border purchases should check Health Canada guidance and bring prescriber documentation to avoid importation issues.

FAQ Section

Can I Stop Verapamil If I Feel Better?

No, do not stop verapamil without consulting your prescriber because abrupt stopping can worsen angina or cause rebound hypertension.

Is Verapamil Covered By My Provincial Drug Plan?

Coverage varies by province and product; check your provincial formulary such as Ontario Drug Benefit, BC PharmaCare, or RAMQ and use the DIN to confirm listed products.

Can I Drink Alcohol Or Have Coffee?

Moderate alcohol may increase dizziness or hypotension when combined with verapamil and should be discussed with your clinician.

Avoid grapefruit juice due to significant interaction risk via CYP3A4 inhibition.

Caffeine can affect blood pressure but does not interact directly with verapamil to a clinically significant extent in most patients.

What If I Miss A Dose?

If you miss a dose, take it as soon as you remember unless it is near the time for your next dose, in which case skip the missed dose and do not double up.

• Checklist: keep a doses log for the first month to avoid double dosing.
• Checklist: bring all medicines to your pharmacy for an interaction check at refill time.
• Emergency signs to watch for: fainting, severe dizziness, very slow pulse, chest pain — seek urgent care.

Guidelines For Proper Use

Pharmacists should verify the DIN, formulation (IR vs ER), and dose at dispensing and counsel patients on common side effects and interactions.

Provincial authorities recommend pharmacist‑led medication reviews such as MedsCheck for older adults and people on multiple medicines.

Baseline checks before initiation should include blood pressure, resting heart rate, and ECG when conduction disease is suspected.

Follow‑up intervals should be arranged to assess blood pressure control, heart rate, constipation, peripheral oedema, and any signs of worsening heart failure.

• Baseline: BP, HR, ECG if indicated, and review of renal and liver function where appropriate.
• Follow‑up: within 1–4 weeks of initiation or dose change to check for side effects and adherence.
• When To Call Your Prescriber: persistent dizziness, syncope, chest pain, marked swelling, or signs of heart failure.

Delivery Across Canada (English)

Final Practical Notes

Check the DIN on your medicine label to confirm the product and strength dispensed by your pharmacy.

Carry an allergy and pacemaker status card in your wallet and add these details to your pharmacy profile, especially in Quebec where bilingual labelling may apply.

Report constipation, ankle swelling, or any troublesome side effects to your pharmacist for practical management tips.

For cost concerns ask your pharmacist about generic verapamil options and provincial plan eligibility such as ODB, PharmaCare, or RAMQ.

In our online pharmacy, calan is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Always consult your prescriber or pharmacist before starting, stopping, or changing verapamil therapy.